0001193125-21-233309.txt : 20211118 0001193125-21-233309.hdr.sgml : 20211118 20210802162651 ACCESSION NUMBER: 0001193125-21-233309 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Context Therapeutics Inc. CENTRAL INDEX KEY: 0001842952 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472566423 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 267-225-7416 MAIL ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 FORMER COMPANY: FORMER CONFORMED NAME: Context Therapeutics LLC DATE OF NAME CHANGE: 20210128 CORRESP 1 filename1.htm CORRESP

August 2, 2021

VIA EDGAR TRANSMISSION

Division of Corporate Finance

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549-6010

 

Attn:

Ada Sarmento

Joe McCann

Division of Corporation Finance

Office of Life Sciences

 

  Re:

Context Therapeutics Inc.

Registration Statement on Form S-1 (Registration No. 333-256572)

Request for Acceleration of Effective Date

Ladies and gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Context Therapeutics Inc. (the “Company”) requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-256572) (the “Registration Statement”) to become effective on August 4, 2021 at 5:00 p.m., Eastern Time, or as soon as practicable thereafter, or at such later time as the Company or its counsel may request via telephone call to the staff. In making this acceleration request, the Company acknowledges that it is aware of its obligations under the Act.

 

Very truly yours,
CONTEXT THERAPEUTICS INC.
By:  

/s/ Martin Lehr

Name:   Martin Lehr
Title:   Chief Executive Officer

 

cc:

Alex Levit, Esq., Context Therapeutics Inc.

Ben Stacke, Esq., Faegre Drinker Biddle & Reath LLP